Author: Medical Channel Asia

Avatar photo

Medical Channel Asia (MCA) is built to be the largest and most reliable health media platform in Asia that supports healthcare professionals in delivering engaging educational content. MCA is growing exponentially on multiple social media and digital platforms with its content catered to the Asian population covering wellness, health and fitness topics.

Singapore, 14 May 2025 – The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils who are on a stable combination of an inhaled corticosteroid (ICS), a long-acting beta2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA), or on a combination of a LABA and a LAMA if ICS is not appropriate.

Log In or Register as a healthcare professional to read the full article.

Read More
The demand for Family Nurse Practitioners (FNPs) in Asia is growing, with online post-master’s certificates providing a flexible pathway for career advancement. These programs equip nurses with essential skills to address primary care shortages while maintaining their professional commitments.

Log In or Register as a healthcare professional to read the full article.

Read More